Stay updated on Molidustat for Dialysis Anemia - Clinical Trial
Sign up to get notified when there's something new on the Molidustat for Dialysis Anemia - Clinical Trial page.

Latest updates to the Molidustat for Dialysis Anemia - Clinical Trial page
- Check6 days agoChange DetectedRemoved non‑essential footer links related to Bayer products and sponsor information, which does not affect the study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision: v3.4.2 is now shown. The previous Notice about government funding status from Revision: v3.4.1 has been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding status was added and the revision tag updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary has been added to the page, and the label for the QC criterion now reads 'Last Update Submitted that Met QC Criteria'. A No FEAR Act Data notice and a revision footer showing 'Revision: v3.4.0' have been added, replacing the previous 'No FEAR Act data' and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4 and the previous Revision: v3.3.3 has been removed.SummaryDifference0.0%

- Check63 days agoChange DetectedNew study locations were added under Contacts and Locations, including Fukuoka, Gifu, Hokkaido, Hyōgo, Ibaraki, Miyagi, Nagano, Osaka, and Tokyo. The HHS Vulnerability Disclosure link was removed from the page.SummaryDifference1.0%

Stay in the know with updates to Molidustat for Dialysis Anemia - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Molidustat for Dialysis Anemia - Clinical Trial page.